Skip to main content

Table 2 1H chemical shifts (in ppm) of the Ga3+-CP04 and Lu3+-CP04 complexes

From: Structural studies on radiopharmaceutical DOTA-minigastrin analogue (CP04) complexes and their interaction with CCK2 receptor

Complex

Amino acid

NH

Other H

Ga3+-CP04

D-Glu1

8.64

4.21

1.90, 2.27

Lu3+-CP04

8.66

4.09

1.99, 2.36

Ga3+-CP04

D-Glu2

8.62

4.26

1.90, 2.27

Lu3+-CP04

8.55

4.25

1.91, 2.02, 2.34

Ga3+-CP04

D-Glu3

8.28

4.24

1.88, 1.96, 2.25

Lu3+-CP04

8.29

4.26

1.95, 2.00, 2.31

Ga3+-CP04

D-Glu4

8.28

4.24

1.88, 1.96, 2.25

Lu3+-CP04

8.29

4.26

1.95, 2.00, 2.31

Ga3+-CP04

D-Glu5

8.33

4.22

1.93, 2.29

Lu3+-CP04

8.25

4.18

1.95, 2.30

Ga3+-CP04

D-Glu6

8.33

4.22

1.93, 2.29

Lu3+-CP04

8.25

4.18

1.95, 2.30

Ga3+-CP04

Ala7

8.30

4.11

1.18

Lu3+-CP04

8.30

4.09

1.18

Ga3+-CP04

Tyr8

7.96

4.37

2.89, 2.95, 6.79, 7.07

Lu3+-CP04

7.96

4.39

2.85, 2.94, 6.80, 7.08

Ga3+-CP04

Gly9

8.10

3.82

 

Lu3+-CP04

8.08

3.83

 

Ga3+-CP04

Trp10

7.74

4.59

3.24, 7.17, 7.20, 7.53, 10.10 (NH)

Lu3+-CP04

7.74

4.63

3.24, 7.10, 7.21, 7.54, 10.09 (NH)

Ga3+-CP04

Met11

7.76

4.15

2.09, 1.66

Lu3+-CP04

7.76

4.14

2.06, 1.67

Ga3+-CP04

Asp12

7.92

4.42

2.43, 2.58

Lu3+-CP04

7.91

4.42

2.46, 2.62

Ga3+-CP04

Phe13

8.05

4.49

2.95, 3.19, 7.15, 7.43

Lu3+-CP04

8.02

4.51

2.94, 3.17, 7.11, 7.44